NEW YORK, Dec. 5, 2006 (PRIME NEWSWIRE) -- Anthony G. Viscogliosi, Chairman & CEO of Small Bone Innovations, Inc. (SBi), will moderate and lead a panel of experts on legal, regulatory and clinical issues during MedTech Insight's "In Spine & Orthopedics" conference on December 11th, 2006 at The Venetian Resort Hotel Casino, Las Vegas, NV. He will also be presenting separately on December 12th an overview of Small Bone Innovations, Inc.
The issues panel, entitled "Creating Your Legal & Regulatory Roadmap for Clinical Success," will discuss the proper integration, management and execution of clinical data collection, intellectual property (IP) protection and regulatory strategy in order to achieve superior value creation. The panel symposium is being sponsored by Musculoskeletal Clinical Regulatory Advisers, LLC (MCRA), a highly specialized firm of leading experts and strategists, committed to developing regulatory, clinical, intellectual property and reimbursement strategies for orthopedic firms worldwide, at all stages of development.
Commenting on the event, Viscogliosi says, "Due to the rapid growth in the use and acceptance of orthopedic implants and devices worldwide, increasingly complicated legal and regulatory pathways have begun to hamper the ability of manufacturers to bring more innovative technologies to surgeons and their patients. I expect the panel to offer highly effective advice and field many questions from company executives who have without a doubt, struggled to clear these hurdles."
Viscogliosi's own company, Small Bone Innovations, Inc., has a significant and impressive portfolio of more than 60 devices for the repair, replacement or regeneration of small bones and joints, an anatomy defined as from the fingertip to the shoulder, and from the toe to below the knee. In the past few weeks, Viscogliosi notes that SBi has introduced several advanced, unique, cutting-edge arthroplasty devices and technology systems, including STABILITY(tm), the market's only bone-conserving, motion-preserving, tissue-sparing sigmoid notch total distal radio-ulna joint (DRUJ) system, and UNI-ELBOW(tm), the only commercially available radio capitellum system on the market. Both systems feature SBi's PGT(tm) Precise Guidance Technology.
Viscogliosi adds, "I am always honored to be able to present the SBi story to educated and informed audiences like those that attend MedTech Insight conferences. Their interest and understanding of the global orthopedic market lends itself to a vibrant exchange of ideas. Those in attendance, new to SBi, will learn not only how we created the small bone & joint market through surgeon-innovated technologies, but also how we strive each day to bring these pain relieving, function-restoring technologies to surgeons and their patients around the world."
For more information on the In Spine & Orthopedics conference, please visit MedTech Insight's website: http://www.medtechinsight.com/inspine-03.html
About Small Bone Innovations, Inc.
Small Bone Innovations, Inc. (SBi) was founded in 2004 by Viscogliosi Bros., LLC, (VB), the New York-based merchant banking firm that specializes in the musculoskeletal /orthopedic sector. VB created SBi as the first company to focus purely on small bone & joint science. By integrating established companies and professionals in the field, SBi today offers a broad, clinically proven portfolio of products and technologies to treat trauma and diseases in small bones & joints. Today, SBi has more than 140 employees at facilities in New York, NY, Morrisville, PA, Minneapolis, MN and Bourg-en-Bresse, France.
VB's acquisitions and technology licenses included: Avanta Orthopaedics, Inc. (hand/wrist/elbow arthroplasty and trauma products - USA); Envision, Inc. (implant manufacturing - USA); Actipore(tm) (porous metal technology - Canada); Artelon(r) (biologically active & biodegradable technology - Sweden); Xtremi-T, LLC (resorbable trauma technology - USA); and Fixano, S.A.S. (broad line of small bone & joint implants - France).
SBi completed a Series B financing, raising a record total of $42.2 million, announced in January, 2006. Based on data provided by Venture Source, this was the largest venture capital investment ever recorded in the field of orthopedic devices. SBi was a 2006 recipient of Red Herring magazine's annual "Red Herring 100 North America" award, recognized as one of the nation's leading technology companies and the only orthopedic device company selected among an initial entry of more than one thousand firms. Additionally, SBi's Artelon CMC-I Spacer, developed for patients with thumb base osteoarthritis, was featured on the cover and highlighted within Medical Design Technology magazine's "Year of Innovation" issue as one of the most fascinating technologies influencing the medical device industry.
For more information on SBi, please visit: www.totalsmallbone.com
About Viscogliosi Bros., LLC
Established by Marc R. Viscogliosi, John J. Viscogliosi and Anthony G. Viscogliosi in New York City in 1999, Viscogliosi Bros., LLC (VB) was the first venture capital/private equity and merchant banking firm dedicated to the musculoskeletal/orthopedics sector of the health care industry.
Today, VB is a leading independent firm with a mission to create, build and finance companies founded on innovations developed by surgeons and uniquely focused on "life changing" musculoskeletal/orthopedic technologies. VB has worldwide surgeon, industry and trade relationships and significant financial expertise in the musculoskeletal/orthopedic sector.
As principals of VB, the Viscogliosi brothers have a combined total of nearly half a century of experience analyzing and investing in the musculoskeletal/orthopedics sector, directing literally billions of dollars through the orthopedics industry. They have pioneered innovative financial, strategic and management initiatives for nearly 150 companies in the sector, from start-up, seed and development stage all the way to exit, while helping thousands of people lead better lives through the orthopedic and spinal products marketed and sold by the companies they have assisted in developing and financing.
The Small Bone Innovations, Inc. logo is available at http://www.primezone.com/newsroom/prs/?pkgid=3091
For more information about VB, please visit: www.vbllc.com
Forward-looking statements
This press release contains forward-looking statements as defined in the U.S. Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on these forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of risks and uncertainties impacting the Company's business including increased competition; the ability of the Company to expand its operations and to attract and retain qualified professionals; technological obsolescence; general economic conditions; and other risks.